Literature DB >> 10516642

Molecular and pharmacological characterization of a functional tachykinin NK3 receptor cloned from the rabbit iris sphincter muscle.

A D Medhurst1, W D Hirst, J C Jerman, J Meakin, J C Roberts, T Testa, D Smart.   

Abstract

1. A functional tachykinin NK3 receptor was cloned from the rabbit iris sphincter muscle and its distribution investigated in ocular tissues. 2. Standard polymerase chain reaction (PCR) techniques were used to clone a full length rabbit NK3 receptor cDNA consisting of 1404 nucleotides. This cDNA encoded a protein of 467 amino acids with 91 and 87% homology to the human and rat NK3 receptors respectively. 3. In CHO-K1 cells transiently expressing the recombinant rabbit NK3 receptor, the relative order of potency of NKB>>NKA>/=SP to displace [125I]-[MePhe7]-NKB binding and to increase intracellular calcium, together with the high affinity of NK3 selective agonists (e.g. senktide, [MePhe7]-NKB) and antagonists (e.g. SR 142801, SB 223412) in both assays was consistent with NK3 receptor pharmacology. In binding and functional experiments, agonist concentration response curves were shallow (0.7 - 0.8), suggesting the possibility of multiple affinity states of the receptor. 4. Quantitative real time PCR analysis revealed highest expression of rabbit NK3 receptor mRNA in iris sphincter muscle, lower expression in retina and iris dilator muscle, and no expression in lens and cornea. In situ hybridization histochemistry revealed discrete specific localization of NK3 receptor mRNA in the iris muscle and associated ciliary processes. Discrete specific labelling of NK3 receptors with the selective NK3 receptor agonist [125I]-[MePhe7]-NKB was also observed in the ciliary processes using autoradiography. 5. Our study reveals a high molecular similarity between rabbit and human NK3 receptor mRNAs, as predicted from previous pharmacological studies, and provide the first evidence that NK3 receptors are precisely located on ciliary processes in the rabbit eye. In addition, there could be two affinity states of the receptor which may correspond to the typical and 'atypical' NK3 receptor subtypes previously reported.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10516642      PMCID: PMC1571693          DOI: 10.1038/sj.bjp.0702854

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  33 in total

1.  Levels of neurokinin A, neurokinin B and substance P in rabbit iris sphincter muscle.

Authors:  T Taniguchi; M Fujiwara; Y Masuo; I Kanazawa
Journal:  Jpn J Pharmacol       Date:  1986-12

2.  Cloning and expression of a rat neuromedin K receptor cDNA.

Authors:  R Shigemoto; Y Yokota; K Tsuchida; S Nakanishi
Journal:  J Biol Chem       Date:  1990-01-15       Impact factor: 5.157

3.  Autoradiographic localization and characterization of tachykinin receptor binding sites in the rat brain and peripheral tissues.

Authors:  P W Mantyh; T Gates; C R Mantyh; J E Maggio
Journal:  J Neurosci       Date:  1989-01       Impact factor: 6.167

Review 4.  Tachykinin receptors and tachykinin receptor antagonists.

Authors:  C A Maggi; R Patacchini; P Rovero; A Giachetti
Journal:  J Auton Pharmacol       Date:  1993-02

5.  Neurokinin receptors in the rabbit iris sphincter characterised by novel agonist ligands.

Authors:  J M Hall; D Mitchell; I K Morton
Journal:  Eur J Pharmacol       Date:  1991-06-18       Impact factor: 4.432

6.  Distribution of messenger RNAs encoding the enzymes glutaminase, aspartate aminotransferase and glutamic acid decarboxylase in rat brain.

Authors:  A Najlerahim; P J Harrison; A J Barton; J Heffernan; R C Pearson
Journal:  Brain Res Mol Brain Res       Date:  1990-05

7.  Chimeric NK1 (substance P)/NK3 (neurokinin B) receptors. Identification of domains determining the binding specificity of tachykinin agonists.

Authors:  U Gether; T E Johansen; T W Schwartz
Journal:  J Biol Chem       Date:  1993-04-15       Impact factor: 5.157

8.  cDNA sequence and heterologous expression of the human neurokinin-3 receptor.

Authors:  R R Huang; A H Cheung; K E Mazina; C D Strader; T M Fong
Journal:  Biochem Biophys Res Commun       Date:  1992-04-30       Impact factor: 3.575

9.  Molecular characterisation, expression and localisation of human neurokinin-3 receptor.

Authors:  G Buell; M F Schulz; S J Arkinstall; K Maury; M Missotten; N Adami; F Talabot; E Kawashima
Journal:  FEBS Lett       Date:  1992-03-24       Impact factor: 4.124

10.  Delineation of structural domains involved in the subtype specificity of tachykinin receptors through chimeric formation of substance P/substance K receptors.

Authors:  Y Yokota; C Akazawa; H Ohkubo; S Nakanishi
Journal:  EMBO J       Date:  1992-10       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.